 a 25% (95% CI, 15-34) proportional reduction in the Ô¨Årst event rate for stroke (4.4%
simvastatin vs 5.7% placebo) (P < .0001), indicating a
28% reduction in ischemic strokes (P < .0001).86 A
Cochrane review investigating the role of statins in primary prevention of cardiovascular disease included 18